Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, Hebron E, Flanagan C, Callander N, Hematti P. Asimakopoulos F, et al. Among authors: hematti p. Leuk Lymphoma. 2013 Oct;54(10):2112-21. doi: 10.3109/10428194.2013.778409. Epub 2013 Apr 11. Leuk Lymphoma. 2013. PMID: 23432691 Free PMC article. Review.
Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Dhakal B, Pagenkopf A, Mushtaq MU, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F. Dhakal B, et al. Among authors: hematti p. Leuk Lymphoma. 2019 Oct;60(10):2558-2562. doi: 10.1080/10428194.2019.1585836. Epub 2019 Mar 8. Leuk Lymphoma. 2019. PMID: 30845856 Free PMC article. No abstract available.
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M. Solomon SR, et al. Among authors: hematti p. Blood Adv. 2019 Oct 8;3(19):2836-2844. doi: 10.1182/bloodadvances.2019000627. Blood Adv. 2019. PMID: 31582392 Free PMC article.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M. Solomon SR, et al. Among authors: hematti p. Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936. doi: 10.1016/j.bbmt.2020.06.029. Epub 2020 Jul 7. Biol Blood Marrow Transplant. 2020. PMID: 32649981 Free PMC article.
Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications.
D'Angelo CR, Hall A, Woo KM, Kim K, Longo W, Hematti P, Callander N, Kenkre VP, Mattison R, Juckett M. D'Angelo CR, et al. Among authors: hematti p. Leuk Res. 2020 Sep;96:106419. doi: 10.1016/j.leukres.2020.106419. Epub 2020 Jul 8. Leuk Res. 2020. PMID: 32683127 Free PMC article. Clinical Trial.
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.
Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS. Mushtaq MU, et al. Among authors: hematti p. Leuk Lymphoma. 2021 Jan;62(1):158-166. doi: 10.1080/10428194.2020.1821009. Epub 2020 Sep 19. Leuk Lymphoma. 2021. PMID: 32951486
228 results